As the EU prepares to introduce regulatory sandboxes for medicines, attention turns to how the new tool can address regulatory hurdles for innovations that do not fit neatly within existing frameworks
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.